Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy,

April 08, 2021 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic … among adults aged 20 – 74. In the United States alone, over 7 million patients suffer …, April 08, 2021 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic … among adults aged 20 – 74. In the United States alone, over 7 million patients suffer …, Read More

Scroll to Top